Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
To access this article, please choose from the options below
PII: S0169-5002(09)00494-2
doi:10.1016/j.lungcan.2009.09.010
© 2009 Elsevier Ireland Ltd. All rights reserved.
